Invention Grant
- Patent Title: Vector construct
-
Application No.: US16760111Application Date: 2018-11-05
-
Publication No.: US11306318B2Publication Date: 2022-04-19
- Inventor: Geir Åge Løset , Terje Frigstad , Sebastian Berge-Seidl , Nicolay Rustad Nilssen , Inger Sandlie
- Applicant: Nextera AS
- Applicant Address: NO Oslo
- Assignee: Nextera AS
- Current Assignee: Nextera AS
- Current Assignee Address: NO Oslo
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: GB1718294 20171103
- International Application: PCT/EP2018/080210 WO 20181105
- International Announcement: WO2019/086681 WO 20190509
- Main IPC: C40B40/08
- IPC: C40B40/08 ; C12N15/70 ; C07K14/005 ; C12N7/00 ; C12N15/10

Abstract:
The present invention provides a vector construct comprising the following components: (i) a sequence encoding a signal peptide which directs proteins into the Tat secretory pathway; and (ii) a sequence encoding a fluorophore fused to a sequence encoding a pVIII phage coat protein. Nucleic acid molecules comprising components (i) and (ii) are also provided, together with phage particles comprising such vectors or nucleic acid molecules and expressing a fluorophore-pVIII fusion protein on the surface. Methods for producing such fluorescent phage particles are also provided.
Public/Granted literature
- US20200255843A1 VECTOR CONSTRUCT Public/Granted day:2020-08-13
Information query